European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact

EAU selected by the European Commission as a member of the Health Technology Assessment (HTA) Stakeholder Network.

The European Association of Urology is thrilled to announce that it has been selected to join the European Commission’s HTA Stakeholder Network.

Mon, 15 May 2023 • Sarah Collen
TechnologyPolicyEuropean CommissionEAU Policy Office

This network has been established as part of the implementation of the HTA Regulation which was agreed by EU institutions and EU member states in 2021, and will come into force in January 2025.The Regulation covers both medicines and medical devices and in vitro diagnostic devices (IVDs).

The Regulation will mean that there will be joint clinical assessments conducted at EU level for all new technologies. There will be a staged entry into force for these joint assessments, starting with cancer therapies and advanced therapies in 2025, followed by orphan medicines in 2028, leading up to 2030 when all new medicines should receive a joint clinical assessment. For medical devices and IVDs, the Commission and member state coordinating group will develop a list of devices that have been selected for joint assessment. The joint clinical assessments will include input from patients and clinical experts, which could include EAU members, particularly from our relevant Clinical Practice Guidelines panels. HTA assessments play an important role in the availability of new technologies for patients across different countries.

“Given the significant ongoing developments in the field of urology, the EAU is delighted to become a member of the HTA stakeholder network. We are committed to working with the European Commission and EU member state authorities to ensure that new medicines and technologies for urological care and diagnosis reach patients that need them in a timely and equitable manner.”
Prof Anders Bjartell, the EAU’s nominated representative

The Stakeholder Network has been created by the Commission to support the Coordination Group from EU member states in the implementation of the joint assessments. The EAU has already provided links to clinical experts for the current voluntary assessments that are taking place at EU level through an EU Joint Action called EUnetHTA (Home - EUnetHTA).

The first meeting of the network will take place in Brussels in June 2023.

Share this article

Suggested for you

See all
About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer